Compound ID | 2941
Ubonodin
Class: RNA synthesis inhibitor
| Agent Type: | Natural product; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | RNA synthesis inhibitor. RNA polymerase inhibitor |
| Target Pathogen: | Active against Burkholderia multivorans and Burkholderia cepacia |
| Description: | Natural product from Burkholderia ubonensis MSMB2207; antimicrobial lasso peptide identified by genome mining |
| Year first mentioned: | 2020 |
| Development status: | Experimental |
| External links: | |
| Guide to Pharmacology: | ubonodin |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205569/ |
| Patent: | US20220380415A1 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.